• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Milla and Alter Announce Yet Another “First Cycle” FDA Approval for Dexmedetomidine Hydrochloride Injection

    BUSINESSWIRE

    Milla`s Generic Dexmedetomidine HydrochlorideReceives Approval in the U.S.

    FDA

    Milla and the Alter Announce Launch of a Generic Version of Magnesium Sulfate

    BUSINESSWIRE

    Milla and Alter Group Announce First Paragraph IV Filing and Acceptance by FDA

    BUSINESSWIRE

    Milla Pharma`s Generic Pyridostigmine Bromide Receives Approval in U.S.

    FDA

    Milla Pharma`s Generic Pyridostigmine Bromide Receives Approval in the U.S.

    FDA

    Third ANDA Approval for Milla Pharma and 4th U.S. Approval for Alter Pharma

    BUSINESSWIRE

    Milla Pharma Announces Approval of a Generic Version of Magnesium Sulfate

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.